Scientists remain among the most trusted voices in American life. In Pew Research Center's latest survey, 77% of U.S. adults said they have at least a fair amount of confidence in scientists to act in the public's best interests, more than business leaders, journalists, or elected officials. But that trust now operates in a fractured information environment: Edelman's 2026 Trust Barometer special report on health found that 70% of people believe at least one divisive health claim, and confidence in the ability to find reliable health answers dropped 10 points in a single year.
That tension is exactly why life science PR matters. Public relations is how a biotech, pharma, medtech, or tools company borrows the credibility of trusted third parties: the trade press your buyers read, the experts they respect, and increasingly the search and AI channels where their first questions get answered. Done well, life science public relations does not just produce press clippings. It builds the reputation that makes every other marketing channel convert better.
This guide covers the complete discipline: why PR works differently in this industry, the six pillars of an effective life science communications program, how PR changes across biotech, pharma, and medtech, how to decide between in-house and agency support, and how to measure what it all produces. It is written for founders and marketing leaders who need PR to justify itself commercially, not just fill a coverage report.
Why Life Science Public Relations Is Different
General-market PR advice assumes a mass audience, an open claims environment, and journalists with time to be charmed. Life science PR gets none of those.
Your audiences read like reviewers. The scientists, clinicians, and executives you need to reach apply professional skepticism to everything, including news coverage. A placement that overstates your data does more damage with this audience than no placement at all. Every story you pitch has to survive contact with an expert reader, which means your narrative can only ever be as strong as the evidence behind it.
The trade press is specialized, small, and stretched. The outlets that matter in this industry are staffed by journalists who know the science and have no patience for spray-and-pray outreach. In Cision's 2026 State of the Media survey of more than 1,800 journalists, most reported receiving 50 or more pitches a week, 86% said they reject pitches that are not relevant to their beat, and half named accuracy and misinformation as their biggest challenge. The bar is relevance and evidence, not volume.
Regulation shapes what you can say. For companies with regulated products, promotional claims are constrained long before a journalist gets involved. In pharma, promotional communications about prescription products fall under the oversight of the FDA's Office of Prescription Drug Promotion. Corporate stories, funding news, and scientific milestones offer more freedom, but the discipline is the same: say what you can support, nothing more.
Coverage now compounds digitally. A placement was once valuable for the readers it reached that week. Today the same story earns a backlink that strengthens your search rankings, a citation that AI assistants repeat when buyers ask for vendor recommendations, and a credibility asset your sales team uses for years. Life science PR and life science SEO are no longer separate disciplines, and programs that treat them separately leave most of the value on the table.
Interactive
The Life Science Media Landscape
Click each channel to see what it is best for and what it costs to earn
Credibility Checks Throughout
Claims discipline | Embargo hygiene | Spokesperson prep | Coverage monitoring
The Six Pillars of Life Science PR
Effective life science communications programs are systems, not stunts. Here are the six pillars, and how to build each one.
Interactive
The Six Pillars of Life Science PR
The system behind an effective communications program - click to explore
77%
Of U.S. adults have at least a fair amount of confidence in scientists (Pew)
86%
Of journalists reject pitches that are not relevant to their beat (Cision)
50+
PR pitches received by most journalists every week (Cision)
84%
Of journalists are open to an introductory email (Cision)
62%
Of journalists use LinkedIn for work, their top platform (Cision)
1. Strategy and Messaging: A Narrative Your Science Can Support
Every strong PR program starts with a story the company can defend: what you do, why it matters now, and what proof exists. Write it down as a message house with a core narrative, supporting pillars, and the evidence behind each claim. Then stress-test it against your own data. If a claim would make your chief scientific officer wince, it does not go in the boilerplate. This is the same claims discipline we recommend in our life science branding work, and it pays off every time a journalist checks.
2. Media Relations: Earn the Trade Press Your Buyers Trust
Life science media relations is a relationship business governed by relevance. The Cision data is unambiguous: 79% of journalists are more likely to engage with a pitch relevant to their beat, 47% want compelling data in the pitch, 45% value embargoed or early access, and 84% are open to a simple introductory email even without a story attached. That last number is the playbook: build the relationship before you need it.
Practical rules that hold up. Build a target list of the 20 to 40 journalists who actually cover your space across outlets like Fierce Biotech, Endpoints News, GEN, BioSpace, and STAT, and read their work before pitching. Lead with the finding, not the company. Offer data, an expert, or an exclusive, and respect embargoes without exception. One relevant pitch to the right reporter beats fifty to a purchased list.
3. Press Releases and Newswires: Announcements That Get Covered
A press release is warranted when something material happens: a financing round, clinical or platform data, a partnership, a major launch, or key hires. It is not a substitute for having news. A strong biotech press release leads with the concrete fact, quantifies it, quotes a named executive saying something a human would say, and includes boilerplate that survives being copied verbatim into an article.
Distribution has two jobs: reaching journalists and creating a citable public record. Wire services such as PR Newswire handle the record and broad syndication (we distribute our own product launches this way), while the coverage that matters usually comes from the direct outreach in pillar 2. Budget accordingly: the wire is the floor, not the strategy.
4. Thought Leadership and KOL Communications: Put Credible Experts Out Front
In a skeptical market, companies are not credible. People are. Life science thought leadership means putting your scientific founders, executives, and partnered key opinion leaders in front of the market with something real to say: bylined articles in the trade press, conference talks, podcasts, and a consistent LinkedIn presence. The channel data supports the focus: in Content Marketing Institute's B2B research, 76% of marketers rated LinkedIn their most effective thought leadership channel, and Cision's survey found LinkedIn is now the platform journalists themselves use most for work (62%). The same executive visibility that earns customer trust also gets your spokesperson into a reporter's source list.
5. Digital PR and SEO: Turn Coverage Into Links, Rankings, and AI Citations
This is the pillar most life science PR programs ignore, and it is where the compounding happens. Every placement should be evaluated partly as a digital asset: does the outlet link to your site, does the story rank for searches your buyers make, and does it feed the AI assistants that increasingly answer "who are the best providers of X" questions. Earned coverage in authoritative outlets is among the strongest backlink sources available to a life science company, and those links raise the rankings of every page on your domain, including the content that generates your leads.
Work the loop deliberately: pitch stories that naturally reference your research or resources, request links when outlets quote your data, republish coverage moments into your own channels, and track which placements AI assistants actually cite. PR that never touches your search visibility is leaving most of its budget on the table.
6. Crisis and Reputation Management: Be Ready Before You Need to Be
Trial setbacks, recalls, layoffs, and safety questions are normal events in this industry, and the companies that weather them decided how they would respond long in advance. The minimum kit: a monitored short list of realistic scenarios, pre-approved holding statements, one designated spokesperson with media training, a clear internal escalation path, and monitoring that catches a developing story early. The goal in a crisis is not to win the news cycle. It is to be accurate, fast, human, and done with it.
How does your brand perform in AI search?
Run a free AEO audit to see how visible your brand is in ChatGPT, Perplexity, and Google AI Overviews.
Life Science PR by Vertical
The pillars hold everywhere. The stories, audiences, and constraints shift by vertical.
Biotech PR
Biotech PR runs on milestones: financings, data readouts, partnerships, and regulatory progress. The audiences are investors, potential partners, and future hires as much as customers, which makes the business and financial press matter alongside the trade outlets. The discipline that separates good biotech PR is honesty about stage: early platform stories should sell the science and the team, not imply outcomes the data does not show. Coordinate announcements with your broader biotech marketing program so coverage moments feed campaigns, not just clip reports.
Pharma PR
Pharma PR splits into corporate communications, which behaves like normal B2B PR, and product communications, which carries regulatory weight. Anything promotional about a prescription product needs the same claims scrutiny as advertising, with OPDP oversight in the US. In practice that means corporate, pipeline, and partnership stories carry most of the earned media load, while product claims stay within approved labeling. Our pharmaceutical marketing strategy guide covers the wider compliance context.
Medical Device and Diagnostics PR
Device and diagnostics stories win on evidence and patient impact: published outcomes, real-world data, and clinician voices. The best programs treat every peer-reviewed publication as a PR event and every KOL relationship as a media asset, feeding both the clinical trade press and the committee-based buying process we mapped in our medical device marketing guide.
In-House or Agency: How to Resource Life Science PR
A capable in-house communicator with real access to leadership beats a distant agency for day-to-day media relations, especially once you pass a handful of announcements a year. Agencies earn their fees when you need established journalist relationships fast, surge capacity around major milestones, senior counsel in a crisis, or specialized reach into markets you do not know.
How to Choose a Life Science PR Agency
If you go the agency route, whether the firm calls itself a life science PR agency, a life science communication agency, or a science communications agency, the evaluation is the same. What matters:
Sector fluency you can test. Ask who will write your materials and have them explain your science back to you in the first meeting. Biotech PR firms live and die on this; generalists reveal themselves in the first paragraph they draft.
Relationships in your actual niche. Ask for recent placements in the specific outlets your buyers read, secured for companies at your stage. Coverage in adjacent industries does not transfer.
Integration with digital. Ask how they connect earned coverage to search rankings, backlinks, and AI visibility, and how that shows up in reporting. If the answer is a monthly clip report, the compounding value in pillar 5 will never materialize.
Ownership and independence. The life science agency market is consolidating fast, and several familiar brands now sit inside larger networks, sometimes alongside the newswires and "best agency" lists they appear in. None of that is disqualifying, but you should know whose interests are in the room: ask who owns the agency, which sister companies they will recommend, and who will actually staff your account after the pitch team leaves.
Measurement beyond clips. Ask what business outcomes they commit to reporting: share of voice against named competitors, links earned, referral traffic, and influenced pipeline. Vanity metrics are a red flag in this discipline more than most.
For the broader evaluation framework, including budget structures and red flags, see our guide to choosing a life science marketing agency.
Measuring Life Science PR
PR measurement fails when it stops at outputs. Track all three layers.
| Layer | What to track |
|---|---|
| Outputs | Placements secured, outlet quality and relevance, share of voice vs named competitors, message pull-through (did your key claim appear) |
| Digital outcomes | Backlinks earned and their authority, referral traffic, branded search volume, rankings lift on linked pages, AI assistant citations of your coverage |
| Business impact | Leads and pipeline influenced by PR touchpoints, sales cycle acceleration on covered accounts, inbound partner and investor conversations |
Two practical notes. First, judge coverage quality over quantity: one story in the outlet your buyers trust outweighs twenty syndicated reprints nobody reads. Second, with 6 to 18 month sales cycles, PR influence shows up in multi-touch attribution and account timelines, not last-click reports, the same measurement reality we describe in our life science lead generation guide.
Five Mistakes That Kill Life Science PR
Watch Out
5 Mistakes That Kill Life Science PR
Click each to learn how to avoid it
Your First 90 Days of Life Science PR
| Phase | Focus | Actions |
|---|---|---|
| Days 1 to 30 | Foundations | Write the message house and claims library. Build the 20 to 40 journalist target list and set up coverage monitoring. Prepare boilerplate, spokesperson bios, and a basic crisis kit. Audit existing coverage and links. |
| Days 31 to 60 | First moves | Send introductory emails to priority journalists (84% welcome them). Ship the first material announcement with direct outreach plus wire distribution. Start the executive LinkedIn cadence. Pitch one bylined article to a trade outlet. |
| Days 61 to 90 | Compound | Convert coverage into links and on-site proof points. Review what landed and why; refine the target list. Establish the measurement dashboard across outputs, digital outcomes, and pipeline influence. Plan the next two announcement moments. |
Where PR Fits in Your Growth Engine
PR earns attention and trust. It pays for itself when that trust lands somewhere built to convert: content that ranks, a website that turns readers into leads, and nurture that carries them through an 18 month cycle. That system is what we build at Marzipan. We are not a PR firm, and this guide should help you choose a specialist confidently if you need one. What we do is make PR pay off: the content and SEO engine that converts coverage into rankings, AI visibility, and pipeline, proven by results like SciLeads' $1.4 million pipeline growth.
If you want your next announcement to produce more than a coverage report, we should talk.
Frequently Asked Questions
| Question | Answer |
|---|---|
| What is life science PR? | Life science PR is the practice of earning credible third-party attention for biotech, pharma, medical device, diagnostics, and research tools companies: coverage in the trade and business press, expert visibility for company leaders, and a public record that builds trust with scientific buyers, investors, and partners. It spans media relations, press releases, thought leadership, digital PR, and crisis management. |
| What does a life science PR agency do? | A life science PR agency develops your narrative and messaging, builds relationships with the journalists who cover your space, writes and distributes announcements, places bylined articles and expert commentary, prepares spokespeople, and manages communications in a crisis. The best firms also connect earned coverage to digital outcomes such as backlinks, search rankings, and AI visibility. |
| How much does life science PR cost? | It varies widely with scope and market. Agency support is typically sold as a monthly retainer that scales with the seniority of the team and the volume of announcements, with project pricing common for one-off launches or funding news. The more useful budgeting question is output-based: what coverage, share of voice, and digital outcomes a given investment should produce, and how that compares to paid channels reaching the same audience. |
| How do you measure life science PR? | Measure three layers: outputs (placements, outlet quality, share of voice, message pull-through), digital outcomes (backlinks, referral traffic, branded search growth, AI assistant citations), and business impact (influenced leads, pipeline, and partner or investor conversations). Given 6 to 18 month sales cycles in this industry, PR influence appears in multi-touch attribution rather than last-click reporting. |
References
- Pew Research Center: Americans' Confidence in Scientists (January 2026)
- Edelman: 2026 Trust Barometer Special Report, Trust and Health
- Cision: PR Lessons from the 2026 State of the Media Report
- Content Marketing Institute: B2B Content and Marketing Trends
- FDA: Office of Prescription Drug Promotion (OPDP)
- PR Newswire
- Fierce Biotech
- Endpoints News
- GEN: Genetic Engineering & Biotechnology News
- BioSpace
- STAT News
Related Reading
- Life Science Marketing: The Complete Guide for 2026
- Life Science Lead Generation: The Complete Guide for 2026
- Life Science Content Marketing: A Data-Driven Guide for 2026
- Life Science SEO: The Complete Guide to Ranking in a Technical Niche
- Biotech Marketing: How to Stand Out in a Crowded Market
- Pharmaceutical Marketing Strategy: A Complete Framework
- How to Choose a Life Science Marketing Agency
Written by
Joe Chamberlain
Head of Digital Marketing
Joe has over a decade of experience delivering high-impact digital strategies for B2B and B2C brands. He's built more than 200 websites and led countless SEO and performance marketing initiatives - each one focused on driving measurable ROI and sustainable growth.
More articles by Joe
